Aurélien de Reyniès

34.2k citations

140 papers · 13.1k indexed · 7 hit papers · h-index 50

Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 25
Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 17
- Cancer Immunotherapy and Biomarkers 17
Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment 13
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 18
- Lymphoma Diagnosis and Treatment 15
Immunology top 1%
Molecular Biology
- Epigenetics and DNA Methylation 11
- Renal and related cancers 11

Co-authors: Pierre Laurent‐Puig Wolf H. Fridman Catherine Sautès‐Fridman Étienne Becht Florent Petitprez Nicolás A. Giraldo Nabila Elarouci Janick Sèlves
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Partner nations: France United States Belgium

In The Last Decade

Aurélien de Reyniès

137 papers receiving 13.0k citations

Hit Papers

7 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
2019 Cancer stemness, intratumoral heterogeneity, and immune response across cancers
2018 Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
2016 Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
2016 Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2013 SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
2006 Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

Peers

Countries citing papers authored by Aurélien de Reyniès

Since Specialization

Citations

This map shows the geographic impact of Aurélien de Reyniès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien de Reyniès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien de Reyniès more than expected).

Fields of papers citing papers by Aurélien de Reyniès

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélien de Reyniès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien de Reyniès. The network helps show where Aurélien de Reyniès may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aurélien de Reyniès, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aurélien de Reyniès Line = papers co-authored together Aurélien de Reyniès links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	239MO: Stratification of pleural mesothelioma patients for combined immunotherapy based on sarcomatoid component and tumour microenvironment markers in the IFCT-MAPS2 study Giovanna Tosato,Yuna Blum,J-B. Assié,Ruth Sequeiros,Alexandra Langlais,Marc‐Antoine Arnould,F. Damiola,E. Amour,Clément Meiller,Marie‐Claude Jaurand,Aurélien de Reyniès,V. Westeel,J. Mazieres,L. Greillier,Franck Morin,Sylvie Lantuéjoul,Arnaud Scherpereel,G. Zalcman,D. Jean	2025	1
2	Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer Laëtitia Marisa,Yuna Blum,Julien Taı̈eb,Mira Ayadi,Camilla Pilati,Karine Le Malicot,Côme Lepage,Ramón Salazar,Daniela Aust,Alex Duval,Hélène Blons,Valérie Taly,David Gentien,Audrey Rapinat,Janick Sèlves,Sophie Mouillet‐Richard,Valérie Boige,Jean‐François Emile,Aurélien de Reyniès,Pierre Laurent‐Puig	2021	37
3	MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma Lisa Kinget,Eduard Roussel,Annelies Verbiest,Maarten Albersen,Cristina Rodríguez‐Antona,Osvaldo Graña‐Castro,Lucía Inglada‐Pérez,Jessica Zucman‐Rossi,Gabrielle Couchy,Sylvie Job,Aurélien de Reyniès,Annouschka Laenen,Marcella Baldewijns,Benoit Beuselinck	2021	19
4	The PAX-FOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition Gloria González Curto,Audrey Der Vartanian,Youcef El-Mokhtar Frarma,Line Manceau,Lorenzo Baldi,Selene Prisco,Nabila Elarouci,Frédéric Causeret,Daniil Korenkov,Muriel Rigolet,Frédéric Aurade,Aurélien de Reyniès,Vincent Contremoulins,Frédéric Relaix,Orestis Faklaris,James Briscoe,Pascale Gilardi‐Hebenstreit,Vanessa Ribes	2020	11
5	Assessing reproducibility of matrix factorization methods in independent transcriptomes Laura Cantini,Ulykbek Kairov,Aurélien de Reyniès,Emmanuel Barillot,François Radvanyi,Andreï Zinovyev	2019	14
6	Cancer stemness, intratumoral heterogeneity, and immune response across cancersbreakdown → Alex Miranda,Phineas T. Hamilton,Allen W. Zhang,Swetansu Pattnaik,Étienne Becht,Artur Mezheyeuski,Jarle Bruun,Patrick Micke,Aurélien de Reyniès,Brad H. Nelson	2019	392
7	Transcriptome Analysis of lncRNAs in Pheochromocytomas and Paragangliomas Sylvie Job,Adrien Georges,Nelly Burnichon,Alexandre Buffet,Laurence Amar,Jérôme Bertherat,Nabila Bouatia‐Naji,Aurélien de Reyniès,D. Drui,Charlotte Lussey‐Lepoutre,Judith Favier,Anne‐Paule Gimenez‐Roqueplo,Luis Jaime Castro‐Vega	2019	13
8	Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma Sylvie Job,Irena Drašković,Nelly Burnichon,Alexandre Buffet,Jérôme Cros,Charles Lépine,Annabelle Vénisse,Estelle Robidel,Virginie Verkarre,Tchao Méatchi,Mathilde Sibony,Laurence Amar,Jérôme Bertherat,Aurélien de Reyniès,Arturo Londoño‐Vallejo,Judith Favier,Luis Jaime Castro‐Vega,Anne‐Paule Gimenez‐Roqueplo	2018	83
9	Polymorphisms in the Von Hippel–Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors Annelies Verbiest,Diether Lambrechts,Thomas Van Brussel,Gabrielle Couchy,Agnieszka Woźniak,Arnaud Méjean,Evelyne Lerut,Stéphane Oudard,Virginie Verkarre,Sylvie Job,Aurélien de Reyniès,Jean‐Pascal Machiels,Jean‐Jacques Patard,Jessica Zucman‐Rossi,Benoit Beuselinck	2018	8
10	Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting Annelies Verbiest,Gabrielle Couchy,Sylvie Job,Jessica Zucman‐Rossi,Laure Caruana,Evelyne Lerut,Raymond Oyen,Aurélien de Reyniès,Brigitte Laguerre,Nathalie Rioux‐Leclercq,Agnieszka Woźniak,Steven Joniau,Hendrik Van Poppel,Kathleen Van den Eynde,Benoit Beuselinck	2017	38
11	Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2 , in Malignant Pleural Mesothelioma Robin Tranchant,Lisa Quetel,Anne Tallet,Clément Meiller,Annie Renier,Leanne de Koning,Aurélien de Reyniès,Françoise Le Pimpec‐Barthes,Jessica Zucman‐Rossi,Marie‐Claude Jaurand,Didier Jean	2016	60
12	Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapybreakdown → Étienne Becht,Aurélien de Reyniès,Nicolás A. Giraldo,Camilla Pilati,Bénédicte Buttard,Laetitia Lacroix,Janick Sèlves,Catherine Sautès‐Fridman,Pierre Laurent‐Puig,Wolf H. Fridman	2016	397
13	Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting Benoit Beuselinck,Sylvie Job,Étienne Becht,Alexandra Karadimou,Virginie Verkarre,Gabrielle Couchy,Nicolás A. Giraldo,Nathalie Rioux‐Leclercq,Vincent Molinié,Mathilde Sibony,Réza Elaidi,Corinne Teghom,Jean‐Jacques Patard,Arnaud Méjean,Wolf H. Fridman,Catherine Sautès‐Fridman,Aurélien de Reyniès,Stéphane Oudard,Jessica Zucman‐Rossi	2015	230
14	Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition Aurélien de Reyniès,Marie‐Claude Jaurand,Annie Renier,Gabrielle Couchy,Ilir Hysi,Nabila Elarouci,Françoise Galateau-Sallé,Marie‐Christine Copin,Paul Hofman,Aurélie Cazes,Pascal Andujar,Sandrine Imbeaud,Fabien Petel,Jean‐Claude Pairon,Françoise Le Pimpec‐Barthes,Jessica Zucman‐Rossi,Didier Jean	2014	100
15	Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity Christian Brambilla,Julien Laffaire,Sylvie Lantuéjoul,Denis Moro‐Sibilot,Hélène Mignotte,François Arbib,Anne‐Claire Toffart,Fabien Petel,Pierre Hainaut,Sophie Rousseaux,Saadi Khochbin,Aurélien de Reyniès,Élisabeth Brambilla	2014	32
16	A Poor Prognosis Subtype of HNSCC Is Consistently Observed across Methylome, Transcriptome, and miRNome Analysis Alain C. Jung,Sylvie Job,Sonia Ledrappier,Christine Macabre,Joseph Abecassis,Aurélien de Reyniès,Bohdan Wasylyk	2013	43
17	Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma Daniel Williamson,Edoardo Missiaglia,Aurélien de Reyniès,Gaëlle Pierron,Bénédicte Thuille,Gilles Palenzuela,Khin Thway,Daniel Orbach,Marick Laé,Paul Fréneaux,Kathy Pritchard‐Jones,Odile Oberlin,Janet Shipley,Olivier Delattre	2010	326
18	Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers Bruno Ragazzon,Rossella Libé,Sébastien Gaujoux,Guillaume Assié,Amato Fratticci,Pierre Launay,Éric Clauser,Xavier Bertagna,Frédérique Tissier,Aurélien de Reyniès,Jérôme Bertherat	2010	117
19	Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival Aurélien de Reyniès,Guillaume Assié,David S. Rickman,Frédérique Tissier,Lionel Groussin,Fernande René-Corail,B. Dousset,Xavier Bertagna,Éric Clauser,Jérôme Bertherat	2009	278
20	Tbx3 Is a Downstream Target of the Wnt/β-Catenin Pathway and a Critical Mediator of β-Catenin Survival Functions in Liver Cancer Claire-Angélique Renard,Charlotte Labalette,Carolina Armengol,Delphine Cougot,Wei Yu,Stefano Cairo,Pascal Pineau,Christine Neuveut,Aurélien de Reyniès,Anne Dejean,Christine Perret,Marie‐Annick Buendia	2007	120

About Aurélien de Reyniès

Aurélien de Reyniès is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 140 papers that have together received 13.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (25 papers), Genetic factors in colorectal cancer (18 papers), Colorectal Cancer Treatments and Studies (17 papers), Cancer Immunotherapy and Biomarkers (17 papers), Lymphoma Diagnosis and Treatment (15 papers), Renal cell carcinoma treatment (13 papers), Epigenetics and DNA Methylation (11 papers) and Renal and related cancers (11 papers). The work is most often cited by research in Cancer Research (4.6k citations), Oncology (4.7k citations) and Pulmonary and Respiratory Medicine (3.7k citations). Aurélien de Reyniès has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Pierre Laurent‐Puig, Wolf H. Fridman, Catherine Sautès‐Fridman, Étienne Becht, Florent Petitprez, Nicolás A. Giraldo, Nabila Elarouci, Janick Sèlves, Laetitia Lacroix and Bénédicte Buttard.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact